What is Leerink Partnrs’ Forecast for ABCL Q1 Earnings?

AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) – Analysts at Leerink Partnrs issued their Q1 2026 earnings per share (EPS) estimates for shares of AbCellera Biologics in a report released on Wednesday, April 16th. Leerink Partnrs analyst P. Souda anticipates that the company will post earnings per share of ($0.16) for the quarter. The consensus […]

Leave a Reply

Your email address will not be published.

Previous post What is DA Davidson’s Estimate for Workday FY2026 Earnings?
Next post Seaport Res Ptn Issues Negative Estimate for SPXC Earnings